Combipatch 0.05-0.14 MG ptch 8S
Ended Awarded
- Contract number
- SPE2DB25FQJGS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,463
Award facts
- Contract value 100% obligated
- $1,463.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $1,463.46, was awarded to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Combipatch 0.05-0.14 mg transdermal patches (8-count) with a completion date of September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The Defense Logistics Agency, under the Department of Defense, is funding this pharmaceutical procurement as part of its Medical Supply Chain operations supporting military and veteran healthcare systems. AmerisourceBergen Drug Corp serves as a prime vendor through the DLA contract vehicle, enabling it to supply a comprehensive range of pharmaceutical products and medical supplies globally. Combipatch is a hormone replacement therapy product used to manage menopausal symptoms, and this order represents a routine fulfillment of medical supply needs for federal healthcare programs. The company's extensive portfolio of federal contracts demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains while maintaining flexible delivery schedules through the DLA's prime vendor framework.
Quick answers
Who was awarded contract SPE2DB25FQJGS?
SPE2DB25FQJGS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FQJGS worth?
The government has obligated $1,463 on SPE2DB25FQJGS.
Is contract SPE2DB25FQJGS an order under another contract?
Yes. SPE2DB25FQJGS is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJGS competed?
The extent of competition for SPE2DB25FQJGS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award